Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000433711

Medchemexpress LLC Abiraterone acetate | 154229-18-2 | 99.91% | C26H33NO2 | 5 MG
SDP

Catalog No. 5000433711
Encompass_Preferred

Abiraterone acetate is an oral, potent, selective, and irreversible inhibitor of CYP17A1 with antiandrogen activity. It is a proagent form of Abiraterone.

  • Oral administration
  • Potent, selective, and irreversible inhibitor of CYP17A1
  • Exhibits antiandrogen activity
  • Prodrug form of Abiraterone
  • Inhibits 17,20-lyase and 17α-hydroxylase activity
  • Inhibits proliferation of AR-positive prostate cancer cell lines
  • Blocks synthesis of 5α-dione and DHT
  • Inhibits CRPC progression
  • Prolongs survival in castration-resistant prostate cancer (CRPC)
  • Inhibits dehydroepiandrosterone (DHEA) depletion and Δ4-androstenedione (AD) accumulation

Catalog No. 50-004-33711 Supplier Medchemexpress LLC Supplier No. HY750545MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Abiraterone acetate is an oral, potent, selective, and irreversible inhibitor of CYP17A1 with antiandrogen activity. It is a proagent form of Abiraterone.

  • Oral administration
  • Potent, selective, and irreversible inhibitor of CYP17A1
  • Exhibits antiandrogen activity
  • Prodrug form of Abiraterone
  • Inhibits 17,20-lyase and 17α-hydroxylase activity
  • Inhibits proliferation of AR-positive prostate cancer cell lines
  • Blocks synthesis of 5α-dione and DHT
  • Inhibits CRPC progression
  • Prolongs survival in castration-resistant prostate cancer (CRPC)
  • Inhibits dehydroepiandrosterone (DHEA) depletion and Δ4-androstenedione (AD) accumulation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.